Skip to main content
. 2012 May 14;2012:837306. doi: 10.5402/2012/837306

Table 2.

Predictive value of K-RAS mutations on overall survival in patients treated with chemotherapy.

Author Setting Total number of patients K-RAS mutations (%) Survival (HR/P value)
Tsao et al. [24] Adjuvant 450 26.0 0.95/0.87
Tsao et al. [37] Adjuvant 1751 19.7 1.18/0.09
Camps et al. [38] Advanced 308 8.8 NR/0.51
Kalikaki et al. [39] Advanced 162 22.6 NR/0.52

HR: hazard ratio; NR: not reported.